Zobrazeno 1 - 7
of 7
pro vyhledávání: ''
Publikováno v:
BMC Ophthalmology
BMC Ophthalmology, Vol 20, Iss 1, Pp 1-7 (2020)
BMC Ophthalmology, Vol 20, Iss 1, Pp 1-7 (2020)
Background Numerous cytokines have been proven to participate in the pathogenesis of neovascular age-related macular degeneration (nAMD). The present study aimed to investigate the aqueous humor cytokine expression profile in nAMD patients before and
Publikováno v:
BMC Ophthalmology
BMC Ophthalmology, Vol 20, Iss 1, Pp 1-9 (2020)
BMC Ophthalmology, Vol 20, Iss 1, Pp 1-9 (2020)
Background It is not clear whether macular laser combined with anti-vascular endothelial growth factor (VEGF) can reduce the number of anti-VEGF injections in the treatment of macular edema (ME) secondary to branch retinal vein occlusion (BRVO). Our
Publikováno v:
BMC Ophthalmology
BMC Ophthalmology, Vol 18, Iss 1, Pp 1-9 (2018)
BMC Ophthalmology, Vol 18, Iss 1, Pp 1-9 (2018)
Background This study sought to identify factors associated with retinal detachment and retreatment of aggressive posterior retinopathy of prematurity (APROP) initially treated with intravitreal ranibizumab (IVR) injection as well as the efficacy of
Publikováno v:
BMC Ophthalmology
Background Acute Multifocal Hemorrhagic Retinal Vasculitis (AMHRV) is a rare disease with unknown incidence that presents with abrupt onset of visual loss associated with retinal vasculitis, retinal hemorrhage, non-confluent posterior retinal infiltr
Autor:
Gerrit Alexander vom Brocke, Tina Dietrich-Ntoukas, Daniel Pilger, Annabelle Eckert, Anne Rübsam, Antonia M. Joussen, Matthias K. J. Klamann, Sibylle Winterhalter, Juliane Schlomberg, Enken Gundlach
Publikováno v:
BMC Ophthalmology
Background Patients with initially low visual acuity were excluded from the therapy approval studies for retinal vein occlusion. But up to 28 % of patients presenting with central retinal vein occlusion have a baseline BCVA of less than 34 ETDRS lett
Publikováno v:
BMC Ophthalmology
Background Controlling retinoblastoma with seeding is challenging despite advances in treatment modalities. Intravitreal melphalan is an alternative to external beam radiation or enucleation for recurrent or refractory vitreous seeds. Significant ocu
Autor:
Young-Jung Roh, Young Gun Park
Publikováno v:
BMC Ophthalmology
Background Retinal angiomatous proliferation (RAP) has been known as a variant of exudative age-related macular degeneration (AMD) with a unfavorable prognosis. To evaluate the effect of ranibizumab administered initially as three loading doses for p